Miotolan is the trade name for the steroid furazabol, which was at one time produced in Japan. Furazabol is a derivative of dihydrotestosterone, but only moderately androgenic in nature. Being DHT based this compound will also not aromatize, so estrogen related side effects such as water retention and gynecomastia are of no concern with use. It also seems to be potent as an anabolic, much more so than dihydrotestosterone. This is no doubt due to alterations in the A ring, which presumably allows the steroid structure to remain stable and bind receptors in muscle tissues long enough to provide an anabolic benefit. The gain received is reportedly not extreme however, and would more closely resemble the hard/quality growth of a non-aromatizing androgen like Masteron.
Furazabol is also shown to have little effect on endogenous testosterone levels when taken in low therapeutic doses. This is likely due to a lack of estrogen conversion; a hormone that we know produces more dramatic inhibition of testosterone production. Of course, all anabolic/androgenic steroids can interfere with normal androgen production given the right dosage, so it is doubtful this tendency will hold true at a performance-enhancing amount. There will probably still be a need for ancillary drugs such as HCG and/or Clomid®/Nolvadex® at the conclusion of a heavy cycle, used to help reestablish a balance of endogenous hormone levels.
The only prominent side effects with furazabol are those associated with its androgenic characteristics. Oily skin, acne, body/facial hair growth, aggression, and hair loss are therefore all possible. Those with a familial predisposition for male pattern baldness should probably look toward nandrolone or Primobolan before this one. Although Proscar® is used effectively to prevent the conversion of testosterone to DHT, it will offer us no benefit with this steroid. Miotolan is already derived from DHT, so its androgenic activity is not intensified by interaction with the 5alpha-reductase enzyme. We should additionally mention that furazabol is a c-17 alpha alkylated compound, and may therefore place unwanted stress on the liver. For this reason it is only to be used for limited periods, typically no longer than 6 or 8 weeks in length.
The main application for this drug is to use it when cutting or preparing for a bodybuilding competition. Here the high androgen content can help bring out an enhanced look of hardness and density to the muscle, especially in the absence of excess estrogen/body fat. Its muscle building activity could be further enhanced by the addition of a mild anabolic such as Deca-Durabolin® or Equipoise®. In this case, the combined androgen/anabolic stack should provide a noteworthy gain of solid, quality muscle mass without a loss of definition due to water bloat. We could alternately use the more potent androgen trenbolone, although here androgenic side effect will be greatly intensified. An acceptable dosage for men, regardless of application, would be in the range of 10-20mg daily (equating to 10-20 tablets). Women might tolerate Miotolan, however, its somewhat prominent androgenic side might make nandrolone a safer option in comparison.
Miotolan has not been manufactured in Japan for years, so there is little chance you will find even residual stock on the black market. With that being said, there is at least one underground manufacturer who claims to be selling legitimate generic furazabol at this time. It is, therefore, very possible this agent is on the black market again. If so, it also means the drug is being made in a legitimate manufacturing facility somewhere. This is good news to Miotolan fans, because it opens the door for other legitimate drug companies to start selling it. This is especially of interest in the West, where we have had minimal, if any, access to the former Japanese product. Until this happens, however, furazabol will remain at best an underground product, and at worst a memory. Therefore, this profile is written more out of interest than practical application.